- VEGFREverolimus in the treatment of metastatic renal cell carcinoma - subanalysis of patients from the RECORD-1 study pretreated with one vs. two VEGFR inhibitors2012 | Second Faculty of Medicine
- News in the systemic treatment of advanced kidney cancer2016 | Publication without faculty affiliation
- Cabozantinib treatment - case report2020 | First Faculty of Medicine
- Predictive diagnostics of gastric cancer in 20182018 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Antiangiogenic therapy for ovarian cancer2013 | First Faculty of Medicine
- Preclinical evaluation of anti-VEGFR2 monoclonal antibody ramucirumab labelled with zirconium-89 for tumour imaging2021 | Faculty of Pharmacy in Hradec Králové
- Preparation, In Vitro Affinity, and In Vivo Biodistribution of Receptor-Specific 68Ga-Labeled Peptides Targeting Vascular Endothelial Growth Factor Receptors2022 | Faculty of Pharmacy in Hradec Králové
- In Vivo Modulation of Angiogenic Gene Expression by Acyclic Nucleoside Phosphonates PMEDAP and PMEG2009 | First Faculty of Medicine
- Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 'CaboGIST'2020 | Publication without faculty affiliation
- Everolimus in the treatment of metastatic renal cell cancer2014 | First Faculty of Medicine
- Tumor angiogenesis2010 | First Faculty of Medicine
- Novel therapeutic targets in non-small cell lung cancer2011 | First Faculty of Medicine
- Regorafenib monotherapy in pretreated metastatic colorectal cancer (CORRECT): an international, multicenter, randomized, placebo-controlled clinical trial Phase 32013 | Second Faculty of Medicine
- Regorafenib - the position of this drug in a current daily oncologic practice2019 | Publication without faculty affiliation
- Antiangiogenic therapy of lung cancer2018 | Second Faculty of Medicine
- Current treatment options for renal cell carcinoma and outlook2020 | Publication without faculty affiliation
- Nintedanib2016 | First Faculty of Medicine
- Axitinib v léčbě metastatického renálního karcinomu2016 | First Faculty of Medicine
- Molecular mechanisms of primary and secondary resistance, molecular-genetic features and characteristics of KIT/PDGFRA non-mutated GISTs2017 | Second Faculty of Medicine
- Komentář ke studii (Nintedanib v léčbě idiopatické plicní fibrózy - analýza výsledků studií II. a III. fáze)2016 | First Faculty of Medicine
- Simultaneous Boron Ion-Channel/Growth Factor Receptor Activation for Enhanced Vascularization2019 | Faculty of Medicine in Pilsen
- Axitinib in the treatment of metastatic renal cell carcinoma2018 | First Faculty of Medicine
- From SARS-CoV-2 to analgesia: harnessing the VEGF-A/NRP-1 axis for pain therapy2023 | Third Faculty of Medicine
- Apoferritin/vandetanib association is long-term stable but does not improve pharmacological properties of vandetanib2021 | Second Faculty of Medicine, Faculty of Science
- Littoral cell angioma of the spleen: a study of 25 cases with confirmation of frequent association with visceral malignancies2016 | Faculty of Medicine in Pilsen, Third Faculty of Medicine
- Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial2021 | First Faculty of Medicine
- Second-generation taxanes effectively suppress subcutaneous rat lymphoma: role of disposition, transport, metabolism, in vitro potency and expression of angiogenesis genes2012 | First Faculty of Medicine
- Analysis of angiogenesis biomarkers for ramucirumab efficacy in patients with metastatic colorectal cancer from RAISE, a global, randomized, double-blind, phase III study2018 | Publication without faculty affiliation
- Tyrosine kinase inhibitors vandetanib, lenvatinib and cabozantinib modulate oxidation of an anticancer agent ellipticine catalyzed by cytochromes P450 in vitro2018 | Faculty of Science